• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Catheters
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Injection Molding
    • Insert molding
    • Tools
  • Materials
    • Advanced Materials
    • Silicone
  • Research & Development
  • Suppliers

MicroVention announces first U.S. clinical case using aneurysm flow diverter Fred X

February 22, 2022 By Danielle Kirsh

microventionMicroVention today announced that the first U.S. clinical case of its flow diverter Fred X device was performed at Thomas Jefferson University Hospital in Philadelphia.

Aliso Viejo, California-based MicroVention received premarket approval for the Fred X device in September. It uses a self-expanding braided nitinol mesh to redirect blood flow and promote aneurysm occlusion. The added X technology reduces the thrombogenicity of the device material and enhances blood vessel healing.

“Fred X represents an important advancement in flow diversion therapy. The X technology surface treatment applied to the Fred X device is designed to reduce material thrombogenicity and has further increased the deliverability of the Fred X,” Stavropoula Tjoumakaris, director of end-vascular surgery and cerebrovascular neurosurgery fellowship at Thomas Jefferson University Hospital and principal investigator of the Fred X post-approval study, said in a news release. “We are excited to be the first center in the U.S. to have clinical experience using the Fred X device and look forward to a clinical study on the benefits of X technology.”

The company’s first iteration of the device, Fred, has been used to treat tens of thousands of patients, according to MicroVention. It received CE mark approval in 2013.

“At MicroVention, we continue to enhance our product portfolio to make meaningful improvements in patient care,” CEO Carsten Schroeder said. “Surface treatment technologies, such as the Fred X device, represent the next frontier in neurovascular therapy, and MicroVention is proud to be able to offer the first of several devices incorporating our X technology to physicians and patients in the U.S.”

Filed Under: Balloons Tagged With: microvention

Primary Sidebar

DeviceTalks Tuesdays

DeviceTalks Tuesdays
MDO ad

Stay Current

Need Medical Tubing news in a minute?
We Deliver!

Medical Tubing + Extrusion newsletter get you caught up on all the mission critical news you need in medical tubing. Sign up today.

Enews Sign up

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

Medical Tubing & Extrusion

Subscribe to our e-newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS